Evidence map›Paper›PMID 31566994›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2019

Reply to H.J.A. Adams et al and C. Kobe et al.

Sally F Barrington, Elizabeth H Phillips, Nicholas Counsell, John Radford

Abstract readComment
PubMed Publisher
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Sally F BarringtonSally F. Barrington, MBBS, MSc, Kings College London, London, United Kingdom; Elizabeth H. Phillips, MB and Nicholas Counsell, MSc, University College London, London, United Kingdom; and John Radford, MD, University of Manchester, Manchester, United Kingdom.
Elizabeth H PhillipsSally F. Barrington, MBBS, MSc, Kings College London, London, United Kingdom; Elizabeth H. Phillips, MB and Nicholas Counsell, MSc, University College London, London, United Kingdom; and John Radford, MD, University of Manchester, Manchester, United Kingdom.
Nicholas CounsellSally F. Barrington, MBBS, MSc, Kings College London, London, United Kingdom; Elizabeth H. Phillips, MB and Nicholas Counsell, MSc, University College London, London, United Kingdom; and John Radford, MD, University of Manchester, Manchester, United Kingdom.
John RadfordSally F. Barrington, MBBS, MSc, Kings College London, London, United Kingdom; Elizabeth H. Phillips, MB and Nicholas Counsell, MSc, University College London, London, United Kingdom; and John Radford, MD, University of Manchester, Manchester, United Kingdom.

Funding

Department of Health RP-2016-07-001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hodgkin DiseaseHumansPositron-Emission TomographyPrognosisRisk AssessmentUnited Kingdom

Identifiers

PMID31566994

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.